MedPath

TAMSULOSIN HYDROCHLORIDE

These highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride. Tamsulosin Hydrochloride Capsules USP*, 0.4 mg Initial U.S. Approval: 1997

Approved
Approval ID

af558603-15f3-43e4-9ee5-9d38d59ef1c1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 19, 2012

Manufacturers
FDA

H.J. Harkins Company, Inc.

DUNS: 147681894

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TAMSULOSIN HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52959-034
Application NumberANDA078938
Product Classification
M
Marketing Category
C73584
G
Generic Name
TAMSULOSIN HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 19, 2012
FDA Product Classification

INGREDIENTS (1)

TAMSULOSIN HYDROCHLORIDEActive
Quantity: 0.4 mg in 1 1
Code: 11SV1951MR
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TAMSULOSIN HYDROCHLORIDE - FDA Drug Approval Details